|
|
Volumn 12, Issue 3, 2002, Pages 131-137
|
|
Drugs in pregnancy
|
|
Author keywords
Abnormalities, drug induced; Fetal development; Pharmacokinetics; Pregnancy complications; Prescription drugs; Teratogens
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMINE OXIDASE (FLAVIN CONTAINING);
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPHOTERICIN B;
ANTIBIOTIC AGENT;
ANTICOAGULANT AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBAMAZEPINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ERYTHROMYCIN;
FLUCONAZOLE;
GABAPENTIN;
HEPARIN DERIVATIVE;
HYDRALAZINE;
LAMOTRIGINE;
LOW MOLECULAR WEIGHT HEPARIN;
METHYLDOPA;
METRONIDAZOLE;
NIFEDIPINE;
NITROFURANTOIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SEROTONIN UPTAKE INHIBITOR;
THIAZIDE DIURETIC AGENT;
TRICYCLIC ANTIDEPRESSANT AGENT;
VALPROIC ACID;
VIGABATRIN;
WARFARIN;
ANXIETY;
CONFERENCE PAPER;
COUNSELING;
DRUG ABSORPTION;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG METABOLISM;
FETOMATERNAL TRANSFUSION;
HUMAN;
PATIENT COMPLIANCE;
PREGNANCY;
PREGNANCY COMPLICATION;
PRENATAL DRUG EXPOSURE;
TERATOGENICITY;
TREATMENT PLANNING;
|
|
EID: 0036235984
PISSN: 09575847
EISSN: None
Source Type: Journal
DOI: 10.1054/cuog.2001.0248 Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (10)
|
